IBUTILIDE FUMARATE (ibutilide fumarate) by Viatris (2) is clinical pharmacology mechanism of action ibutilide fumarate injection prolongs action potential duration in isolated adult cardiac myocytes and increases both atrial and ventricular refractoriness in vivo , ie, class iii electrophysiologic effects. Approved for atrial fibrillation. First approved in 2024.
Drug data last refreshed 20h ago
CLINICAL PHARMACOLOGY Mechanism of Action Ibutilide fumarate injection prolongs action potential duration in isolated adult cardiac myocytes and increases both atrial and ventricular refractoriness in vivo , ie, class III electrophysiologic effects. Voltage clamp studies indicate that ibutilide…
Worked on IBUTILIDE FUMARATE at Viatris (2)? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.